{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:10:25Z","timestamp":1789589425343,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/JRF\/BET-16\/1\/2016\/AL\/37-458"],"award-info":[{"award-number":["DBT\/JRF\/BET-16\/1\/2016\/AL\/37-458"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.msec.2021.112335","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T11:55:24Z","timestamp":1627386924000},"page":"112335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Preparation and characterization of withaferin A loaded pegylated nanoliposomal formulation with high loading efficacy: In vitro and in vivo anti-tumour study"],"prefix":"10.1016","volume":"128","author":[{"given":"Prathapan","family":"Abeesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walsan Kalarikkal","family":"Vishnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekharan","family":"Guruvayoorappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.msec.2021.112335_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.msec.2021.112335_bb0010","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4324-2016150477","article-title":"Liposome and Their Applications in Cancer Therapy.","volume":"59","author":"Pandey","year":"2016","journal-title":"Braz Arch Biol Technol"},{"issue":"10","key":"10.1016\/j.msec.2021.112335_bb0015","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bcp.2012.08.027","article-title":"Molecular insight in the multifunctional activities of Withaferin A","volume":"84","author":"Berghe","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.msec.2021.112335_bb0020","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-13-2081","article-title":"Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.","volume":"74","author":"Nagalingam","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.msec.2021.112335_bb0025","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.7314\/APJCP.2014.15.4.1711","article-title":"Effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer.","volume":"15","author":"Cai","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.msec.2021.112335_bb0030","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","article-title":"Withaferin A targets heat shock protein 90 in pancreatic cancer cells.","volume":"79","author":"Yu","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.msec.2021.112335_bb0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/15384047.2015.1046651","article-title":"Anti-cancer activity of withaferin A in B-cell lymphoma.","volume":"16","author":"McKenna","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.msec.2021.112335_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107596","article-title":"Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells.","volume":"9","author":"Kakar","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.msec.2021.112335_bb0045","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/carcin\/bgr192","article-title":"Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.","volume":"32","author":"Munagala","year":"2011","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.msec.2021.112335_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.15430\/JCP.2015.20.3.185","article-title":"Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity.","volume":"20","author":"Choi","year":"2015","journal-title":"J Cancer Prev."},{"issue":"3","key":"10.1016\/j.msec.2021.112335_bb0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/ijms17030290","article-title":"Withaferin-A - A Natural Anticancer Agent with Pleitropic Mechanisms of Action.","volume":"17","author":"Lee","year":"2016","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.msec.2021.112335_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/02841869609098486","article-title":"Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo.","volume":"35","author":"Sharada","year":"1996","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.msec.2021.112335_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaim.2018.12.008","article-title":"Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial.","volume":"11","author":"Pires","year":"2020","journal-title":"J Ayurveda Integr Med."},{"issue":"9","key":"10.1016\/j.msec.2021.112335_bb0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/pharmaceutics12090863","article-title":"Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells.","volume":"12","author":"El-Shafie","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.msec.2021.112335_bb0075","first-page":"554","article-title":"Nanoencapsulation of Withaferin-A Using Poly-(Lactic Acid) for Enhanced Anxiolytic Activity","volume":"14","author":"Khan","year":"2013","journal-title":"Middle East J. Sci. Res."},{"issue":"2","key":"10.1016\/j.msec.2021.112335_bb0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12668-020-00819-w","article-title":"Formulation Development and Characterization of Withaferin-A Loaded Polymeric Nanoparticles for Alzheimer\u2019s Disease","volume":"11","author":"Madhu","year":"2021","journal-title":"BioNanoScience"},{"key":"10.1016\/j.msec.2021.112335_bb0085","article-title":"Preparation and characterization of anticancer niosomal withaferin\u2013A formulation for improved delivery to cancer cells: In vitro, in vivo, and in silico evaluation","volume":"59","author":"Shah","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.msec.2021.112335_bb0090","article-title":"NGRKC16-lipopeptide assisted liposomal-withaferin delivery for efficient killing of CD13 receptor-expressing pancreatic cancer and angiogenic endothelial cells","volume":"58","author":"Jaggarapu","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.msec.2021.112335_bb0095","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/03639045.2017.1300169","article-title":"Nanoethosomal formulation of gammaoryzanol for skin-aging protection and wrinkle improvement: a histopathological study.","volume":"43","author":"Heydari","year":"2017","journal-title":"Drug Dev Ind Pharm."},{"issue":"1","key":"10.1016\/j.msec.2021.112335_bb0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1556-276X-6-482","article-title":"Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate.","volume":"6","author":"Abreu","year":"2011","journal-title":"Nanoscale Res Lett."},{"key":"10.1016\/j.msec.2021.112335_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.112649","article-title":"PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: in vitro and in vivo assessment","volume":"303","author":"Singh","year":"2020","journal-title":"J. Mol. Liq."},{"issue":"2","key":"10.1016\/j.msec.2021.112335_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers.","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.msec.2021.112335_bb0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.colsurfb.2017.04.046","article-title":"Withaferin-A, a steroidal lactone encapsulated mannose decorated liposomes ameliorates rheumatoid arthritis by intriguing the macrophage repolarization in adjuvant-induced arthritic rats.","volume":"155","author":"Sultana","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"5","key":"10.1016\/j.msec.2021.112335_bb0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.28932\/jmh.v2i5.1129","article-title":"Combination of Cisplatin-Withaferin Based on PEGylated Liposome Nanoparticles as Alternative Therapy for Ovarian Cancer.","volume":"2","author":"Yani","year":"2020","journal-title":"J. Med. Health"},{"issue":"2","key":"10.1016\/j.msec.2021.112335_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-5394.1999.07205.x","article-title":"Perception of chemotherapy side effects cancer versus noncancer patients","volume":"7","author":"Lindley","year":"1999","journal-title":"Cancer Pract"},{"issue":"3","key":"10.1016\/j.msec.2021.112335_bb0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/ijms17030290","article-title":"Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.","volume":"17","author":"Lee","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.msec.2021.112335_bb0135","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.25938","article-title":"Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation","volume":"129","author":"Thaiparambil","year":"2011","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.msec.2021.112335_bb0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","article-title":"Liposomal paclitaxel formulations.","volume":"163","author":"Koudelka","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.msec.2021.112335_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.01.002","article-title":"Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation.","volume":"448","author":"Tian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.msec.2021.112335_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BSR20090104","article-title":"Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics","volume":"30","author":"Deniz","year":"2010","journal-title":"Biosci Rep"},{"key":"10.1016\/j.msec.2021.112335_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fbio.2015.12.002","article-title":"Vitamin A palmitate-bearing nanoliposomes: Preparation and characterization","volume":"13","author":"Pezeshky","year":"2016","journal-title":"Food Biosci."},{"key":"10.1016\/j.msec.2021.112335_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2018.08.034","article-title":"Nanomedicines for the treatment of hematological malignancies.","volume":"287","author":"Deshantri","year":"2018","journal-title":"J Control Release."},{"issue":"1\u20132","key":"10.1016\/j.msec.2021.112335_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.msec.2021.112335_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejps.2005.01.020","article-title":"Atomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomes.","volume":"25","author":"Ruozi","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.msec.2021.112335_bb0175","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/S0142-9612(03)00331-4","article-title":"Physico-chemical stability of colloidal lipid particles. Biomaterials.","volume":"24","author":"Heurtault","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2021.112335_bb0180","first-page":"3087","article-title":"Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes.","volume":"6","author":"Zhao","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.msec.2021.112335_bb0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/IJN.S119895","article-title":"Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer.","volume":"12","author":"Wei","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"15","key":"10.1016\/j.msec.2021.112335_bb0190","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.","volume":"26","author":"Win","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2021.112335_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6750-5-12","article-title":"A simple technique for quantifying apoptosis in 96-well plates.","volume":"5","author":"Ribble","year":"2005","journal-title":"BMC Biotechnol."},{"issue":"1","key":"10.1016\/j.msec.2021.112335_bb0200","first-page":"332","volume":"25","author":"Yin","year":"2020","journal-title":"J BUON"},{"issue":"5","key":"10.1016\/j.msec.2021.112335_bb0205","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-199142050-00005","article-title":"Cyclophosphamide toxicity. Characterising and avoiding the problem.","volume":"42","author":"Fraiser","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.msec.2021.112335_bb0210","doi-asserted-by":"crossref","first-page":"w14030","DOI":"10.4414\/smw.2014.14030","article-title":"Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases","volume":"144","author":"Dan","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"10.1016\/j.msec.2021.112335_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1254\/jphs.94.177","article-title":"Antitumor activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in Swiss albino mice.","volume":"94","author":"Gupta","year":"2004","journal-title":"J Pharmacol Sci."},{"issue":"3","key":"10.1016\/j.msec.2021.112335_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/cbt.72","article-title":"Cycling to cancer with cyclin D1.","volume":"1","author":"Diehl","year":"2002","journal-title":"Cancer Biol Ther."},{"issue":"1","key":"10.1016\/j.msec.2021.112335_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/mp.51.1.1","article-title":"Cyclin D1 and human neoplasia.","volume":"51","author":"Donnellan","year":"1998","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.msec.2021.112335_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","article-title":"Ki-67 protein as a tumour proliferation marker. Clin Chim Acta. 2019 Apr;491:39-45. doi: 10.1016\/j.cca.2019.01.011.","volume":"491","author":"Menon","year":"2019","journal-title":"Clin Chim Acta"}],"updated-by":[{"DOI":"10.1016\/j.msec.2021.112432","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121004756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121004756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:37:31Z","timestamp":1760535451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493121004756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":46,"alternative-id":["S0928493121004756"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2021.112335","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.msec.2021.112432","asserted-by":"object"}]},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and characterization of withaferin A loaded pegylated nanoliposomal formulation with high loading efficacy: In vitro and in vivo anti-tumour study","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2021.112335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112335"}}